Brief: CytRx announces positive interim mis-stage aldoxorubicin results as a treatment for hiv-related kaposi's sarcoma

LadRx

08/01/2015 14:02

Jan 8 (Reuters) - CytRx Corp  CYTR.O : 
 * Announces positive interim phase 2 aldoxorubicin results as a treatment for 
   hiv-related kaposi's sarcoma (ks) 
 * Says aldoxorubicin showed 66% complete or partial responses and no tumor 
   progression in ks patients with excellent tolerability 
 
 * Source text for Eikon  ID:nPn6lNCJs  
 
 * Further company coverage  CYTR.O   
 
 ((Bengaluru Newsroom; +1 646 223 8780))